|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ann Thorac Surg 1995;60:1340
© 1995 The Society of Thoracic Surgeons
Department of Surgery, New England Deaconess Hospital, Harvard Medical School, 110 Francis St, Suite 2C, Boston, MA 02215
| The first 20% of the full text of this article appears below. |
See also page 1337.
Data gathered over many years in lung cancer resulted in not only the establishment of a therapy-based staging system but also the initiation of well-defined surgical protocols for early-stage disease and carefully constructed trials for late stage disease. Some would argue that pretherapy staging in esophageal cancer is not so important. However, earlier detection of operable esophageal cancers, particularly in patients with Barrett's
Related Article
Ann. Thorac. Surg. 1995 60: 1337-1340.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |